Data Science for Precision Oncology
Event details
| Date | 21.12.2023 |
| Hour | 17:00 |
| Speaker | Prof. Olivier Michielin, M.D., Ph.D., Director of Oncology Department and Head of precision oncology services, Geneva University Hospital (HUG), Geneva (CH) |
| Location | |
| Category | Conferences - Seminars |
| Event Language | English |
BIOENGINEERING SEMINAR
Abstract:
AI algorithms used in diagnosis and prognosis of precision oncology must be explainable. In the wake of AI and ML powered diagnostics and medical devices, one of the biggest challenges today of utilizing AI in clinical practice is the reluctance of physicians to adopt something they do not understand and often regard as a black box.
Bio:
Olivier Michielin obtained a Masters of Physics in 1991 at the EPFL, Lausanne, and a Medical Degree from the University of Lausanne (UNIL) in 1997. He pursued his PhD training under the supervision of Jean-Charles Cerottini (Ludwig Institute for Cancer Research, Lausanne) and Martin Karplus (Harvard and Strasbourg Universities, Chemistry Nobel Prize Laureate 2013). He was appointed Group Leader of the Swiss Institute of Bioinformatics in 2002 and became an Assistant Professor at the Medical Faculty at UNIL in 2004. In parallel, he trained as medical oncologist and obtained his board certification in 2007 at the Department of Oncology of the Lausanne University Hospital (CHUV). Prof. Michielin's main focus is on translational and precision oncology, developing new molecularly defined therapeutic approaches based on original bioinformatics techniques developed in his laboratory, as well as precision oncology programs based on multi-omics strategies and data science at the national level. Prof. Olivier Michielin currently serves as Chair of the Department of Oncology and the Precision Oncology Service at the Geneva University Hospital (HUG); he is also Head of the Precision Oncology Center at CHUV and co-Director of the Swiss Cancer Center Léman (SCCL) in Lausanne.
Abstract:
AI algorithms used in diagnosis and prognosis of precision oncology must be explainable. In the wake of AI and ML powered diagnostics and medical devices, one of the biggest challenges today of utilizing AI in clinical practice is the reluctance of physicians to adopt something they do not understand and often regard as a black box.
Bio:
Olivier Michielin obtained a Masters of Physics in 1991 at the EPFL, Lausanne, and a Medical Degree from the University of Lausanne (UNIL) in 1997. He pursued his PhD training under the supervision of Jean-Charles Cerottini (Ludwig Institute for Cancer Research, Lausanne) and Martin Karplus (Harvard and Strasbourg Universities, Chemistry Nobel Prize Laureate 2013). He was appointed Group Leader of the Swiss Institute of Bioinformatics in 2002 and became an Assistant Professor at the Medical Faculty at UNIL in 2004. In parallel, he trained as medical oncologist and obtained his board certification in 2007 at the Department of Oncology of the Lausanne University Hospital (CHUV). Prof. Michielin's main focus is on translational and precision oncology, developing new molecularly defined therapeutic approaches based on original bioinformatics techniques developed in his laboratory, as well as precision oncology programs based on multi-omics strategies and data science at the national level. Prof. Olivier Michielin currently serves as Chair of the Department of Oncology and the Precision Oncology Service at the Geneva University Hospital (HUG); he is also Head of the Precision Oncology Center at CHUV and co-Director of the Swiss Cancer Center Léman (SCCL) in Lausanne.
Practical information
- Informed public
- Free